FDA approved the ANDA for Metformin Hydrochloride manufactured by Ascend Laboratories, LLC, granting the firm market authorization for the generic version of the widely used type 2 diabetes medication. This diversification of supply chains could improve commercial viability for the manufacturer, though the approval faces a limited commercial window given the popular launch of branded generics by Mylan in 2016.